The Potential for Molecular Treatment Strategies in Lymphatic Disease
- 1 December 2004
- journal article
- review article
- Published by Mary Ann Liebert Inc in Lymphatic Research and Biology
- Vol. 2 (4) , 173-181
- https://doi.org/10.1089/lrb.2004.2.173
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammationTrends in Immunology, 2004
- Role of lymphangiogenic factors in tumor metastasisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2004
- Mutations in the Transcription Factor Gene SOX18 Underlie Recessive and Dominant Forms of Hypotrichosis-Lymphedema-TelangiectasiaAmerican Journal of Human Genetics, 2003
- Immune Traffic: A Functional OverviewLymphatic Research and Biology, 2003
- FOXC2 haploinsufficient mice are a model for human autosomal dominant lymphedema-distichiasis syndromeHuman Molecular Genetics, 2003
- FOXC2 truncating mutation in distichiasis, lymphedema, and cleft palateClinical Genetics, 2002
- Therapeutic lymphangiogenesis with human recombinant VEGF‐CThe FASEB Journal, 2002
- Molecular control of lymphangiogenesisBioEssays, 2002
- The Specificity of Receptor Binding by Vascular Endothelial Growth Factor-D Is Different in Mouse and ManJournal of Biological Chemistry, 2001
- The anatomy and development of the jugular lymph sacs in the domestic cat (Felis domestica)Journal of Anatomy, 1910